Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.10 (2.70%)
Spread: 0.20 (5.405%)
Open: 3.70
High: 3.80
Low: 3.70
Prev. Close: 3.70
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

Mon, 06th Mar 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Amur Minerals Corp, up 57% at 1.58 pence, 12-month range 0.6p-3.28p. The natural resources explorer completes the USD35 million disposal of 100% of its interest in AO Kun-Manie, to Bering Minerals. Kun-Manie is a wholly-owned subsidiary of Irosta, which is Amur's wholly-owned subsidiary. Will pay out a special dividend of 1.8p within 90 days of receipt of the sale funds. Back in November, Amur said it faced delays to the sale, due to restrictions on transferring funds to Russia. "We are pleased to have achieved the sale of Kun-Manie which will enable the company to move forward in a new direction, which we envision will result in shareholders seeing real value," says CEO Robin Young.

----------

Plexus Holdings PLC, up 40% at 4p, 12-month range 1.6p-6.2p. The engineering services provider secures an order for its wellhead equipment and sealing technology for a specialised project application. Under the GBP5 million contract, its Pos-Grip HG equipment and technology will be deployed over the next 12 months. About GBP2.5 million will be received via milestone payments in the current financial year ending June 30, with the remainder to be recognised as sales revenue in financial 2024. CEO Been van Bilderbeek says the contract "significantly increases the visibility of [the firm's] future revenue and cash flow projections, and Plexus' reputation as a "can do" surface or subsea equipment solutions provider.

----------

AIM - LOSERS

----------

Fusion Antibodies PLC, down 33% at 32p, 12-month range 30p-110p. The antibody developer says revenue and earnings for the year ending March 31 are expected to be "significantly" behind market expectations, with revenue to be no less than GBP2.8 million. This is due to continuing uncertainty over the timing of several anticipated orders, which is outside the firm's control. As Fusion shifts its focus on larger integrated service contracts, it notes "very positively received" discussions with several potential clients.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
4 May 2021 19:13

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

Read more
16 Feb 2021 14:24

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

Read more
11 Feb 2021 11:16

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Read more
20 Nov 2020 13:25

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Read more
13 Nov 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Oct 2020 15:15

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

Read more
24 Sep 2020 16:35

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

Read more
18 Sep 2020 21:16

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Read more
18 Sep 2020 15:45

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 Sep 2020 09:48

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.

Read more
19 Aug 2020 09:15

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Read more
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
6 Jul 2020 16:02

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

Read more
6 Jul 2020 10:41

Fusion Antibodies FY revenues continue to grow in 2020

(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.